Ipsen is a global specialty-driven pharmaceutical company with total sales exceeding €1.2 billion in 2013. Ipsen’s ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases. Its development strategy is supported by three franchises: urology-oncology, endocrinology and neurology. Moreover, the Group has an active policy of partnerships. Ipsen's R&D is focused on its innovative and differentiated technological platforms, peptides and toxins. In 2012, R&D expenditure totaled close to €250 million, representing more than 20% of Group sales. The Group has close to 4,900 employees worldwide.
Established in Dublin in 1989, Ipsen Manufacturing Ireland Ltd is a specialised bulk Peptide Active Pharmaceutical Ingredient facility employing over 100 people. The plant supplies the active ingredient for two of the group’s major products.
Please enter your email address
Reporting to the Manufacturing area Owner, the successful candidate will perform daily production operations in line with overall objectives for productivity, timeliness and cost in compliance with GMP and EHS expectations.